Literature DB >> 18462735

Annexin V expression in human placenta is influenced by the carriership of the common haplotype M2.

Elena Chinni1, Giovanni Luca Tiscia, Donatella Colaizzo, Patrizia Vergura, Maurizio Margaglione, Elvira Grandone.   

Abstract

In a group of placentas from patients with preeclampsia or fetal growth restriction, reduced annexin V gene expression in those carrying the M2 haplotype was observed. This is the first "ex vivo" demonstration that annexin V gene expression in placentas is dependent on the M2 haplotype.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18462735     DOI： 10.1016/j.fertnstert.2007.12.056

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  11 in total

1.  Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.

Authors:  Xiao-Xuan Wu; Seth Guller; Jacob H Rand
Journal:  Am J Obstet Gynecol       Date:  2011-06-24       Impact factor: 8.661

2.  The haplotype M2 of the ANXA5 gene is not associated with antitrophoblast antibodies.

Authors:  Nina Rogenhofer; Laura Engels; Nadja Bogdanova; Frank Tüttelmann; Arseni Markoff; Christian J Thaler
Journal:  J Assist Reprod Genet       Date:  2013-03-27       Impact factor: 3.412

3.  Assessment of M2/ANXA5 haplotype as a risk factor in couples with placenta-mediated pregnancy complications.

Authors:  Nina Rogenhofer; Lara R M Nienaber; Lea C Amshoff; Nadia Bogdanova; David Petroff; Peter Wieacker; Christian J Thaler; Arseni Markoff
Journal:  J Assist Reprod Genet       Date:  2017-09-13       Impact factor: 3.412

4.  The relevance of ANXA5 genetic variants on male fertility.

Authors:  Heloisa Lopes Lavorato; Arseni Markoff; Valeria Altholz; Nadja Bogdanova; Peter Wieacker; Sabine Kliesch; Stefan Schlatt
Journal:  J Assist Reprod Genet       Date:  2019-06-13       Impact factor: 3.412

5.  Maternal carriers of the ANXA5 M2 haplotype are exposed to a greater risk for placenta-mediated pregnancy complications.

Authors:  Federico Aranda; Sebastián Udry; Silvia Perés Wingeyer; Lea Christina Amshoff; Nadja Bogdanova; Peter Wieacker; José Omar Latino; Arseni Markoff; Gabriela de Larrañaga
Journal:  J Assist Reprod Genet       Date:  2018-03-01       Impact factor: 3.412

6.  Genetic analysis of the M2/ANXA5 haplotype as recurrent pregnancy loss predisposition in the Malay population.

Authors:  Kai-Cheen Ang; Sushilnathan Kathirgamanathan; Ewe Seng Ch'ng; Yan-Yeow Lee; Anna-Liza Roslani; Bavanandan Naidu; Krishna Kumar; Ridzuan Abdullah; Siti-Nadiah Abdul Kadir; Narazah Mohd Yusoff; Wan Zaidah Abdullah; Nadja Bogdanova; Peter Wieacker; Arseni Markoff; Thean-Hock Tang
Journal:  J Assist Reprod Genet       Date:  2017-01-20       Impact factor: 3.412

7.  Obstetric complication-associated ANXA5 promoter polymorphisms may affect gene expression via DNA secondary structures.

Authors:  Hidehito Inagaki; Sayuri Ota; Haruki Nishizawa; Hironori Miyamura; Kumiko Nakahira; Machiko Suzuki; Sachie Nishiyama; Takema Kato; Itaru Yanagihara; Hiroki Kurahashi
Journal:  J Hum Genet       Date:  2019-02-22       Impact factor: 3.172

8.  Hereditary thrombophilic risk factors for recurrent pregnancy loss.

Authors:  Nadja Bogdanova; Arseni Markoff
Journal:  J Community Genet       Date:  2010-06-11

9.  Maternal and paternal carriage of the annexin A5 M2 haplotype: a possible risk factor for recurrent implantation failure (RIF).

Authors:  Nina Rogenhofer; Arseni Markoff; Xenia Ennerst; Nadja Bogdanova; Christian Thaler
Journal:  J Assist Reprod Genet       Date:  2020-11-24       Impact factor: 3.412

10.  Precision Medicine in Assisted Conception: A Multicenter Observational Treatment Cohort Study of the Annexin A5 M2 Haplotype as a Biomarker for Antithrombotic Treatment to Improve Pregnancy Outcome.

Authors:  Simon Fishel; Deborah Baker; Janine Elson; Maha Ragunath; Glenn Atkinson; Adel Shaker; Ahmed Omar; Rahnuma Kazem; Ashley Beccles; Ian A Greer
Journal:  EBioMedicine       Date:  2016-07-18       Impact factor: 8.143
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.